Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.36.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.21NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.122.2 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.79 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-4360.53China
AQ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.1.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.209NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.236NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.33NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XQNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.59NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.395NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.120.2.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.416.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.532NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.408NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XHNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.133NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.18NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.466NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.489NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.363NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.95NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.26NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.531NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.45NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.200NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.299NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.55NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.149NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.300NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.179NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.25NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.125NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
G.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.438NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.35NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.178NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.208NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.197NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.491NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EV.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.8 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.39.3 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.8.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.75.3 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.35NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used